GlaxoSmithKline (GSK) is one of the world's leading research-based pharmaceutical and healthcare companies - committed to improving the quality of human life by enabling people to do more, feel better and live longer. GSK undertakes research to identify treatments to overcome diseases including cancer, asthma, depression, obesity and pain. In addition, GSK is involved in the prevention of disease with the development of vaccines. The company also produces many consumer healthcare products including: Aquafresh toothpaste, Lucozade, Beecham’s Powders, Nurofen, Panadol, and Piriteze.

A clinical trial is a research study designed to answer specific questions about vaccines, new therapies or new ways of using known treatments. Clinical trials (often referred to as medical research, drug trials or research studies) are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people

The CUC Cambridge is based at Addenbrookes Hospital and specialises in early phase studies of potential new medicines in Healthy Volunteers (phase 1) and occasionally Patients (phase 2). We also undertake a range of experimental medicine trials. It is here where we undertake studies to evaluate how new drugs can be used most effectively to help people. Medication in the early phases of development need healthy volunteers to assess how the drugs are absorbed and excreted by the body. It takes several years before a new drug can be prescribed for patients. It is important to appreciate that any medication prescribed for patients today, is the result of people, who in the past, have volunteered to participate in medical research.

We need healthy people now to help us develop medication for the future.